Clinical Laboratory
Expert Laboratory Testing Capabilities
The CLIA-Certified, Infectious Diseases Clinical Laboratory has served the Louisville and southern Indiana communities for more than 50 years. We offer diagnostic testing services to local and regional hospitals, clinics, private physician practices, long-term care facilities, and private businesses. Through these systems we serve over 6,000 patients and perform over 12,000 tests annually. Our experts have over 150 collective years of experience and are available to offer consultations in our diagnostic specialty areas.
Category Definition of Testing
- Laboratory Developed Tests (LDT)
- Analyte Specific Reagent (ASR)
- Emergency Use Authorization (EUA)
- Food and Drug Administration Approved Test (FDA)
UofL ID Lab Test Menu
Explore the full library of diagnostic tests we currently offer. Each assay is set up Monday through Friday, with final results usually available by 2:00 pm on day of receipt.
A Local, CLIA-Certified Diagnostic Testing Laboratory
The Infectious Diseases Laboratory provides the utmost quality in clinical laboratory testing, while strictly adhering to all federal, state, and local laws. As such, we are committed to maintaining a relevant and active compliance program to protect our patients and clients.
Privacy at the University of Louisville
The University of Louisville is responsible for complying with the requirements of HIPAA that are relevant to those areas of the University covered by HIPAA regulations. This includes those areas that have been designated to be within the University's health care component (Infectious Diseases Laboratory). Such compliance promotes a culture that adheres to the requirements of the regulations and values and protects the privacy and security of the Protected Health Information within its possession. The University's Administrative policy is available at University of Louisville HIPAA/Privacy Policy.
Reporting to Public Health
One of two reportable test the Infectious Diseases Laboratory performs is the Macro-Vue® RPR (Rapid Plasma Reagin) test. It is a serological test used to screen asymptomatic individuals for syphilis, diagnose symptomatic infection, and monitor disease activity and response to treatment. This a qualitative test and the results are either non-reactive or reactive. Reactive values are reported to the health care provider for appropriate treatment and additional testing decisions, such as the need for an RPR titer and TPPA (Treponema pallidum particle agglutination) test. An RPR titer and/or TPPA testing is performed at the Louisville Metro Public Health and Wellness Laboratory, 430 E. Gray St., Louisville, KY 40202. The second reportable test is the Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) real-time PCR assay. It is a laboratory-developed test performed on the Luminex Aries® instrument on urine samples for the diagnosis of chlamydia and/or gonorrhea urogenital disease. The CT/NG assay is an automated in vitro diagnostic test for qualitative detection of genomic bacterial DNA. The results for each analyte are either DNA Not Detected or DNA Detected. If CT and/or NG is detected the results are reported to the health care provider for appropriate treatment and faxed to the Louisville Metro Public Health and Wellness Laboratory.
Reporting to a Healthcare Facility
A healthcare facility is notified by the Infectious Diseases Laboratory when a positive test result is obtained for the following tests: SARS CoV-2, Chlamydia pneumoniae, Legionella pneumophila, Mycoplasma pneumoniae, Pneumocystis jirovecii, Chlamydia trachomatis, Neisseria gonorrhoeae, and any tick-borne agent such as Pan-Ehrlichia, Anaplasmosis phagocytophilum, Lyme, and Rickettsia spotted fever or typhus group. It is the responsibility of the submitting healthcare facility to report any of the aforementioned organisms to their local public health agency if applicable.